TD Cowen raised the firm’s price target on Addus HomeCare (ADUS) to $140 from $139 and keeps a Buy rating on the shares. The firm updated its model following Q3 results.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ADUS:
- Addus HomeCare Reports Strong Q3 2025 Results
- Addus Homecare: Strategic Growth and Strong Financial Performance Justify Buy Rating
- Addus HomeCare Q3 2025 Earnings: Growth Amid Challenges
- Addus HomeCare price target raised to $117 from $111 at Barclays
- Addus HomeCare Reports Strong Q3 2025 Financial Results